One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v118.21.1875.1875
Copy DOI Journal: Blood |  Publication Date: Nov 18, 2011 |
 Citations: 3 |
Affiliation: University of Chicago, Mount Sinai Medical Center, Emory University, Hackensack University Medical Center, Princess Margaret Cancer Centre, Moffitt Cancer Center, Northwestern University, Mayo Clinic, City Of Hope National Medical Center, Multiple Myeloma Research Foundation, University of Calgary, University of British Columbia, The University of Texas MD Anderson Cancer Center, Roswell Park Cancer Institute, University of California, San FranciscoUnfavorable Cytogenetic Characteristics Do Not Adversely Impact Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Single-Agent Carfilzomib on the 003 (A1) Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
